Episode Details
Back to EpisodesOculis Announces Phase 3 Results for DME Eye Drops
Published 10 hours ago
Description
Oculis Releases phase 3 data for its investigational eye drop for DME; Rayner expands its surgical offerings with the launch of a new OVD; and a biosimilar referencing Eylea is launched in Europe.
Learn more about your ad choices. Visit megaphone.fm/adchoices